MSR1 and type 2 diabetes mellitus: To our knowledge, this is the first research study to analyze the expression of SRs (LOX-1, MSR1, CD36, CXCL16 and CL-P1), CD68, CD11c and CD206 in EAT in patients with IHD, stratifying by T2DM status.